Source link : https://www.newshealth.biz/health-news/denosumab-raises-hypocalcemia-risk-in-chronic-kidney-disease/
TOPLINE: Denosumab treatment for osteoporosis raises the risk for hypocalcemia, which worsens with advancing stages of chronic kidney disease (CKD), in those with CKD–Mineral and Bone Disorder (CKD-MBD) and in those undergoing dialysis. METHODOLOGY: There is a paucity of data regarding treatments for osteoporosis in patients with advanced CKD, who often develop CKD-MBD, a clinical […]
Author : News Health
Publish date : 2024-11-21 12:05:32
Copyright for syndicated content belongs to the linked Source.
Categories